Clinical Trials Logo

Colchicine Adverse Reaction clinical trials

View clinical trials related to Colchicine Adverse Reaction.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05168137 Recruiting - HIV Infections Clinical Trials

Efficacy and Safety of Low-Dose Colchicine on Surrogate Markers of Cardiovascular Events in People Living With HIV Receiving Antiretroviral Therapy

Start date: February 1, 2020
Phase: Phase 4
Study type: Interventional

In a double-blind, randomized controlled trial, we assigned PLWH receiving ART without a history of cardiovascular events to received colchicine 0.6 mg once daily or placebo. The primary endpoint was the mean difference of hs-CRP, IL-6, and IL-1 Ra levels at three and six months. The secondary endpoint was to access safety outcomes.